Ovatemp is a technology company.
Ovatemp has raised $120K across 1 funding round.
Ovatemp has raised $120K in total across 1 funding round.
# Ovatemp: A Fertility Health Technology Platform
Ovatemp is a mobile-based fertility management platform that combines a smartphone app with hardware to help women track and improve their reproductive health[1][2]. Founded in 2012 and headquartered in Boston/Newton, Massachusetts, the company serves women trying to conceive or seeking to enhance their fertile health across their reproductive lifespan—from puberty to menopause[1][2].
The core problem Ovatemp addresses is the fragmented, manual nature of fertility tracking. Rather than offering a simple tracker like competitors, Ovatemp delivers personalized fertility plans with data-driven recommendations tailored to each user's fertility profile[1]. The platform integrates natural fertility awareness methods—specifically basal body temperature and cervical fluid monitoring—with modern technology and holistic wellness guidance rooted in Traditional Chinese Medicine[3]. This positions Ovatemp as a non-hormonal alternative for women seeking to understand and optimize their reproductive health naturally.
Ovatemp was founded in 2012 by Daniel Graf (CEO) and Ana Mayer (Chief Fertility Officer)[1]. The company's genesis reflects a deliberate fusion of traditional fertility knowledge and modern technology. Mayer partnered with Jill Blakeway, a licensed acupuncturist and board-certified herbalist recognized by the New York Times as a "fertility goddess," to develop fertility enhancement programs grounded in proven strategies from the YinOva Center[3]. This collaboration gave Ovatemp credibility in both the wellness and reproductive health spaces.
The company achieved early traction through Techstars backing and raised $700,000 in angel funding by the time of its public launch from beta[1][4]. The founding team identified a clear market gap: women needed a smarter, more integrated approach to fertility management that combined tracking with actionable, personalized guidance.
Ovatemp operates at the intersection of femtech, digital health, and the wellness movement—sectors experiencing significant growth as women increasingly seek agency over their health decisions. The company rides several tailwinds: growing skepticism of hormonal contraceptives, rising interest in natural family planning methods, and the broader digitization of healthcare.
The timing is particularly relevant given the post-2016 surge in femtech investment and the normalization of discussing reproductive health in mainstream tech. Ovatemp's non-hormonal positioning also aligns with a cultural shift toward holistic wellness and personalized medicine, making it relevant to health-conscious women across multiple demographics.
By combining app-based personalization with FDA-cleared hardware, Ovatemp influences the broader ecosystem by demonstrating that fertility tech can transcend simple tracking to become a comprehensive health management platform. This raises the bar for competitors and validates the market opportunity for integrated reproductive health solutions.
Ovatemp's trajectory depends on successful commercialization of ONDO and scaling its subscription user base. The company's ability to generate clinical evidence supporting its personalized recommendations—and to achieve FDA clearance for its hardware—will be critical differentiators as the femtech space becomes increasingly competitive and regulated.
Looking ahead, Ovatemp is positioned to expand beyond fertility optimization into broader reproductive health management across women's lifespans. As digital health becomes more personalized and hardware-software integration becomes standard, Ovatemp's early bet on this model could position it as a category leader in women's reproductive health technology.
Ovatemp has raised $120K in total across 1 funding round.
Ovatemp's investors include Firebrand Ventures.
Ovatemp has raised $120K across 1 funding round. Most recently, it raised $120K Seed in March 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2015 | $120K Seed | Firebrand Ventures |